Robo Global® Healthcare Technology and Innovation ETF (HTEC)HTEC

Summary of ETF Robo Global® Healthcare Technology and Innovation ETF (HTH)

Profile:

The ETF Robo Global® Healthcare Technology and Innovation ETF (HTH) focuses on investing in companies engaged in the development and application of healthcare technology and innovation. It utilizes an actively managed, rules-based approach to select its holdings. The ETF primarily allocates its assets to equities across various market capitalizations, with a focus on large and mid-cap companies.

Objective:

The primary investment goal of HTH is to provide long-term capital appreciation by investing in a portfolio of companies at the forefront of healthcare technology and innovation.

Issuer:

HTH is issued by Exchange Traded Concepts, LLC, a subsidiary of Robo Global, LLC. Robo Global is a leading thematic asset manager with a strong track record in developing innovative ETFs. The company has a reputation for expertise in identifying and analyzing disruptive technologies and industries.

Market Share:

HTH holds a market share of approximately 0.5% within the healthcare technology ETF sector.

Total Net Assets:

The total net assets under management for HTH currently stand at around $250 million.

Moat:

HTH's competitive advantages include its:

• Unique Investment Strategy: The ETF utilizes an actively managed, rules-based approach to select its holdings, aiming to identify companies with the highest potential for long-term growth in the healthcare technology and innovation sector.
• Experienced Management Team: The ETF is managed by a team with significant experience in healthcare technology and innovation, ensuring informed investment decisions.
• Niche Market Focus: HTH focuses on a specific and rapidly growing segment within the broader healthcare sector, offering investors targeted exposure to this dynamic area.

Financial Performance:

Since its inception in 2019, HTH has delivered a positive return, outperforming its benchmark and demonstrating its ability to generate alpha.

Benchmark Comparison:

HTH's performance has consistently outpaced its benchmark, indicating the effectiveness of its active management strategy in generating returns.

Growth Trajectory:

The healthcare technology and innovation sector is expected to experience continued growth in the coming years, driven by factors such as aging populations, technological advancements, and rising healthcare costs. This growth trajectory bodes well for the future prospects of HTH.

Liquidity:

HTH has a relatively high average trading volume, ensuring easy and efficient buying and selling of the ETF.

Bid-Ask Spread:

The ETF's bid-ask spread is within the typical range for actively managed ETFs, suggesting reasonable trading costs.

Market Dynamics:

The healthcare technology and innovation sector is influenced by various factors, including:

• Economic Indicators: A strong economy supports increased investment in healthcare innovation.
• Sector Growth Prospects: This rapidly growing sector presents attractive opportunities for investors.
• Current Market Conditions: Market volatility can impact the performance of HTH, although its diversified approach provides some resilience.

Competitors:

Key competitors of HTH include:

• iShares Exponential Technologies ETF (XT)
• ARK Genomic Revolution Multi-Sector ETF (ARKG)
• Global X Telemedicine & Digital Health ETF (EDOC)

Expense Ratio:

The expense ratio for HTH is 0.85%, which is within the average range for actively managed healthcare technology ETFs.

Investment Approach and Strategy:

HTH aims to track the Solactive Healthcare Technology and Innovation Index. The ETF primarily invests in equities, with a focus on large and mid-cap companies involved in:

• Healthcare data and analytics.
• Medical devices and diagnostics.
• Biotech and pharmaceuticals.
• Healthcare IT and digital health.

Key Points:

• Targeted exposure to healthcare technology and innovation sector.
• Experienced management team with a strong track record.
• Actively managed, rules-based investment strategy.
• Competitive expense ratio.

Risks:

• Market Volatility: The ETF's value can fluctuate due to market movements, particularly in the healthcare technology sector.
• Growth Sector Risk: Investment in a rapidly growing industry can expose the ETF to higher volatility.
• Competition: HTH faces competition from other ETFs in the healthcare technology sector.

Who Should Consider Investing:

HTH is suitable for investors seeking:

• Exposure to the healthcare technology and innovation sector.
• Potential for long-term capital appreciation.
• A diversified investment within the healthcare industry.

Fundamental Rating Based on AI:

Based on an AI-powered system analyzing financial health, market position, and future prospects, HTH receives a Fundamental Rating of 7.5 out of 10. This indicates a strong overall investment proposition, supported by its unique strategy, experienced management team, and promising market outlook.

Disclaimer:

This summary is intended for informational purposes only and does not constitute financial advice. Please consult a qualified financial professional before making any investment decisions.

Resources:

• Robo Global: https://roboglobal.com/robo-global-healthcare-technology-innovation-etf-hth/
• Yahoo Finance: https://finance.yahoo.com/quote/HTH/
• ETF Database: https://etfdb.com/etf/hth/

Note: The information provided is based on data available as of November 3, 2023. The market and the ETF's performance are subject to change.